Press Releases

<< Back
Nov 26, 2018

Mylan to Present at Nasdaq's 39th London Investor Conference

HERTFORDSHIRE, England and PITTSBURGH, Nov. 26, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will present at Nasdaq's 39thLondon Investor Conference on Tuesday, Dec. 4, 2018, at 9:45 a.m. GMT/4:45 a.m. ET.

Mylan (PRNewsfoto/Mylan N.V.)

Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's website at investor.mylan.com. An archived version also will be available following the live presentation and can be accessed at the same location for a limited time.

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com. We routinely post information that may be important to investors on our website at investor.mylan.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/mylan-to-present-at-nasdaqs-39th-london-investor-conference-300755162.html

SOURCE Mylan N.V.

Christine Waller (Media) 724.514.1968; Melissa Trombetta (Investors) 724.514.1813

Email Alerts
Investor FAQs
Contact Us
LinkedIn